Detall de la convocatòria
Característiques
| Característica |
|---|
|
Objectiu de la convocatòria
The ”la Caixa” Foundation (hereinafter “LCF”) is supporting the Iberian ecosystem of biomedical innovation by helping to successfully transfer scientific knowledge to society through products, services, devices and businesses. |
|
Característiques principals
Eligible Projects must be from the life sciences field, in the specific scientific areas corresponding to the European Research Council Peer Review Evaluation Panels categorisation detailed in Annex 1. Within the scientific areas defined above, the Asset/s must belong to one of the following business areas: |
|
Lloc de presentació
El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a: Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.05.76. Marta López: mlopez4@imim.es Ext.: 1576 Mercedes Bayo: mbayo@imim.es Ext.: 1684 |
|
Convocatòria (URL)
https://fundacionlacaixa.org/es/caixaimpulse-convocatoria-innovacion-salud-descripcion https://fundacionlacaixa.org/documents/2278030/4048616/caixaimpulse-health-innovation-rules-participation-2023.pdf FAQS: https://fundacionlacaixa.org/es/caixaimpulse-convocatoria-innovacion-salud-faqs Sol·licitud: https://convocatorias.fundacionlacaixa.org/s_Login.jsp?&lang=1&_ga=2.263839503.223788537.1676020419-2071509305.1595493484&_gl=1*1lpdv5y*_ga*MjA3MTUwOTMwNS4xNTk1NDkzNDg0*_ga_7NE4JXPZHV*MTY3NjAyMDQxOS4xMi4xLjE2NzYwMjA3ODAuMC4wLjA. Launch: 13 February 2023 |
|
Informació addicional
The Programme is organised in Stages according to the needs of each Project: » Stage 1 is designed to support Projects that are generating a Proof of Concept of the hypothesis of value from scientific findings for a potential Asset/s and initiating the search for IP Right protection. It provides funds up to EUR 50,000 over a maximum period of 24 months. » Stage 2 is designed to support Projects that have already identified and characterised the Asset/s through proof of concept validation and are refining the prototype design through validation of the intended use (e.g. evaluating its sensitivity, efficiency and/or safety; initiating animal model development for the desired indication, or identifying preclinical compound candidates, optimisation, etc.). It provides funds up to EUR 150,000 over a maximum period of 24 months. » Stage 3 is designed to support Projects that are on the path to regulatory filing and require an advanced characterisation of the Asset/s (e.g. performance testing, identification of clinical sites, etc.), need to refine financial viability strategies and/or are exploring exploitation models. It provides funds up to EUR 500,000 over a maximum period of 24 months. Projects may enter the Programme in any of the Stages. Projects may also progress from one stage to another within the Programme through evaluation checkpoints (see Section 7). |
|
Documentació
To initiate the submission process, Project Leaders will need to complete the online application form available on the LCF application platform and provide the required documentation (https://grants.lacaixafoundation.org/) Applications must be completed in English The Project Leader will require the approval of the Applicant Institution to be able to submit the application. The application process will entail two steps: the initial submission of a Proposal (pre-selection process), and the subsequent invitation for a presentation and interview (selection process) with the Evaluation Committee in case of pre-selection. A template for the Proposal will be available on the LCF online application platform. The following information and documentation will be requested: If applying for Stages 2 and 3, the following additional information will be requested: If applying for Stage 3, this additional information will be requested: |